香雪品牌怎么样 申请店铺

我要投票 香雪在中草药行业中的票数:163 更新时间:2025-02-05
香雪是哪个国家的品牌?「香雪」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东,由创始人王永辉在1986期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
香雪怎么样

广州市香雪制药股份有限公司总部位于广州经济技术开发区科学城,是一家以中成药制药和研发为主业,集西药制药、生物医学工程和药材规范种植于一体的现代化高新技术医药企业。

公司秉承“厚生臻善维新”的企业理念,坚持“崇尚品质;关爱健康”的质量方针,坚持自主创新、自主品牌,在品质、技术、研发、品牌和规模等多方面成长为行业领先者,得到消费者、行业和政府主管部门的高度评价和广泛认可,其中“香雪”商标获评中国驰名商标,“香雪抗病毒口服液”获评广东省名牌和广州市名牌产品,香雪制药获评“《福布斯》中国成长企业潜力榜100强”前五位,香雪制药获评“广东省医药产业50强企业”和“广州2010年亚运会药品供应商”等。

香雪制药一直致力于质量创新,致力于中药现代化的研究和实践,1998年开始进行中药现代化关键技术指纹图谱质量控制技术的研究,并取得重大突破。2001年,香雪抗病毒口服液指纹图谱质控研究被纳入广州名优中成药品种指纹图谱质量控制示范研究项目。2000年,香雪制药本着“实施中药系列标准规范,提高中成药品种质量”的理念,承担了国家科技部的“九五”重点科技攻关项目广藿香GAP种植基地,经过一年多的探索与研究,现已被国家科技部列入第一批国家中药现代化科技产业化(广东)基地,并通过国家验收。

香雪制药本着高起点、高技术、高标准、高速度的现代企业发展战略,采用先进的技术、工艺、设备,形成了完善、科学、先进的生产体系,使公司的产品质量和主要技术指标均达到了国内先进水平。公司坚持“创新”为企业的灵魂,以科技进步推动企业的发展。近年来承担了多项国家及省、市级重大科技专项技术的研究与开发;本着生产一代、储备一代、研制一代、构思一代的新产品开发战略。加快了疗效确切、科技含量高的新产品的研制开发。

Guangzhou Xiangxue Pharmaceutical Co., Ltd., headquartered in Science City, Guangzhou Economic and Technological Development Zone, is a modern high-tech pharmaceutical enterprise with Chinese patent medicine and R & D as its main business, integrating western medicine, biomedical engineering and standard planting of medicinal materials. The company adheres to the enterprise concept of "great life, perfect and innovative", and adheres to "advocating quality"; The company adheres to the quality policy of "care for health", adheres to independent innovation and independent brand, grows into the industry leader in quality, technology, R & D, brand and scale, and is highly appraised and widely recognized by consumers, industry and government authorities. Among them, "Xiangxue" trademark is awarded the famous trademark in China, and "Xiangxue antiviral oral liquid" is awarded the famous brand in Guangdong Province and Guangzhou city Brand products, Xiangxue pharmaceutical won the top five "Forbes China growth enterprise potential list top 100", Xiangxue pharmaceutical won the "top 50 pharmaceutical enterprises in Guangdong Province" and "drug supplier of Guangzhou 2010 Asian Games" and so on. Xiangxue pharmaceutical has been committed to quality innovation, research and practice of the modernization of traditional Chinese medicine. In 1998, it began to study the key technology of the modernization of traditional Chinese medicine fingerprint quality control technology, and made a major breakthrough. In 2001, the fingerprint quality control research of Xiangxue antiviral oral liquid was included in the quality control demonstration research project of Guangzhou famous and excellent Chinese patent medicine. In 2000, in line with the concept of "implementing the standards and specifications of traditional Chinese medicine series and improving the quality of traditional Chinese medicine varieties", Xiangxue pharmaceutical undertook the patchouli gap planting base, a key scientific and technological key project of the Ninth Five Year Plan of the Ministry of science and technology of the people's Republic of China. After more than a year's exploration and research, it has been listed in the first batch of national bases for the modernization of science and technology industrialization of traditional Chinese medicine (Guangdong) by the Ministry of science and technology of the people's Republic of China and passed the national acceptance 。 Based on the modern enterprise development strategy of high starting point, high technology, high standard and high speed, Xiangxue pharmaceutical adopts advanced technology, process and equipment to form a perfect, scientific and advanced production system, so that the product quality and main technical indicators of the company have reached the advanced level in China. The company adheres to "innovation" as the soul of the enterprise and promotes the development of the enterprise with the progress of science and technology. In recent years, it has undertaken the research and development of a number of national, provincial and municipal major science and technology special technologies; in line with the new product development strategy of production generation, storage generation, development generation and conception generation. The research and development of new products with precise curative effect and high technology content are accelerated.

本文链接: https://brand.waitui.com/f0447df2d.html 联系电话:020-22211555

千城特选小程序码

7×24h 快讯

房地产融资协调机制工作专班有关负责人:目前万科房地产项目建设正在平稳有序推进中

房地产融资协调机制工作专班有关负责人表示,从专班掌握的情况看,2024年,万科交付住房超过18万套,全面完成保交房目标任务。从各地城市房地产融资协调机制工作专班了解的情况看,目前万科房地产项目建设正在平稳有序推进中,“白名单”制度将提供有力的融资支持,充分保障项目建设交付。(中国建设报)

2小时前

迪士尼第一财季营收247亿美元,同比增长5%

2月5日,华特迪士尼公司发布截至2024年12月28日的2025财年第一季度业绩:营收为247亿美元,同比增长5%;摊薄后每股收益为1.40美元,同比增长35%。(界面)

2小时前

李强:锚定发展目标因时因势加大逆周期调节力度,聚焦突出问题整合资源集中发力

国务院总理李强2月5日主持召开国务院第七次全体会议。李强指出,要系统化创造性地抓好落实。既要注重整体把握,综合平衡好国内和国外、当前和长远、宏观和微观、发展和安全等关系,在多重目标中找到有效路径,也要寻求突破突围,找准潜力足、空间大的发展领域,谋划好牵引性强、撬动性强的工作抓手,打造更多能够带动全局的突出亮点。要认真总结和丰富拓展工作中探索的好做法,锚定发展目标因时因势加大逆周期调节力度,聚焦突出问题整合资源集中发力,敢于打破常规推出可感可及的政策举措,及时回应关切加强政策与市场的互动。(新华社)

2小时前

李强:采取有力举措在做强国内大循环、推动科技创新、促进产业升级等重点领域实现新突破

国务院总理李强2月5日主持召开国务院第七次全体会议。李强强调,要以更加强烈的担当、更加积极的作为推动高质量发展取得新成效。要坚定信心、知难共进,客观辩证看待外部形势变化,统筹解决国内经济问题和应对外部挑战,变压力为动力,采取有力举措在做强国内大循环、推动科技创新、促进产业升级等重点领域实现新突破,并着眼长远打造我国发展新优势。(新华社)

2小时前

杭钢股份:公司与DeepSeek系统的开发、应用等核心技术无关

36氪获悉,杭钢股份公告,公司关注到媒体有关于子公司DeepSeek部署适配的相关报道,公司主营业务为钢铁及其压延产品的生产和销售。钢铁及相关业务营业收入占比超过总额的90%。短期内,公司主营业务不会发生变化。相关媒体报道中涉及的DeepSeek部署适配是指,在上述业务模式下,公司在合作伙伴的系统中安装DeepSeek软件,安装后将算力设备对外提供租赁服务。公司与DeepSeek系统的开发、应用等核心技术无关,且与杭州深度求索人工智能基础技术研究有限公司无任何业务往来。

2小时前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询